NVS

Q: What is the price of Novartis (NVS) today?

The price of Novartis (NVS) today is $ 126.54, with return of 26.61% compared to the last year. The price of Novartis (NVS) started the year trading around $ 97.14 and today it is at $ 126.54. Follow the real-time price chart, the historical price of Novartis (NVS) and international markets.

Q: When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of April, totaling $ 3.87. The Dividend Yield for the last 12 months is 3.04%.

Q: Is Novartis (NVS) worth it?

Currently, Novartis (NVS) is priced at $ 126.54, with a P/E of 17.04%, representando um desvio de 2,448% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 26.61 in its price and distributed $ 3.87 in dividends, resulting in a Dividend Yield of 3.04%. The total shareholder return was 26.61%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Novartis (NVS) stock?

Investing in stocks of Novartis (NVS) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Novartis (NVS) yield today?

The yield of Novartis (NVS) was -2.93% in the last month, 26.61% in the last year and 83.29% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 3.87 in dividends, a Dividend Yield of 3.04%.If you wanted to buy 100 stocks of Novartis (NVS) today, the total investment would be $ 12,654.00, based on the current price of $ 126.54.If past performance were to repeat, the return on your investment would be:In 1 year: $ 16,021.23In 5 years: $ 23,193.52In 10 years: $ 30,030.47It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Novartis AG

Price

$ 126.54

return (12m)

26.61%

p/e

17.04

p/bv

5.48

DIVIDEND YIELD

3.04%

price NVS

BVMF

NVS

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of NVS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.93%

3 months

-0.08%

1 year

26.61%

2 years

39.35%

5 years

83.29%

10 years

137.32%

Fundamentals NVS

review the fundamentals of Novartis shares

P/E

17.04

Sector: -2.16 Industry: -4.35

P/SALES RATIO (PSR)

4.35

Sector: 1.99 Industry: 2.82

P/BV

5.48

Sector: 2.12 Industry: 1.99

DIVIDEND YIELD (DY)

3.04%

Sector: - Industry: -

ROA

13.42%

Sector: -26.99% Industry: -53.23%

ROE

32.16%

Sector: -30.03% Industry: -43.96%

ROIC

16.37%

Sector: -414.93% Industry: -472.50%

NET MARGIN

25.53%

Sector: -27.97% Industry: -32.87%

GROSS MARGIN

76.21%

Sector: 44.10% Industry: 45.08%

OPERATING MARGIN

31.15%

Sector: -24.33% Industry: -29.79%

P/EBITDA

10.69

Sector: -0.32 Industry: -3.32

P/EBIT

13.98

Sector: -2.46 Industry: -4.39

P/ASSET

2.29

Sector: 1.19 Industry: 1.35

BVPS

23.24

Sector: 3.38 Industry: 1.66

EPS

7.47

Sector: -0.89 Industry: -1.28

EQUITY RATIO

0.42

Sector: 0.43 Industry: 0.46

CAGR REVENUE 5 YEARS

2.47%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

12.26%

Sector: - Industry: -

FAIR VALUE OF Novartis ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 126.54

Fair Value

$ 0.00

Upside Return potential.

-50.61%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NVS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	51.55	39.80	77.20%	0.55%	$ 949.16 B	30.99%
ISRG	72.99	11.76	16.12%	0.00%	$ 200.49 B	28.58%
TMO	33.80	4.34	12.84%	0.29%	$ 222.07 B	15.02%
SNY	10.79	1.50	13.90%	4.46%	$ 121.64 B	14.83%
MDT	27.23	0.00	0.00%	2.79%	$ 129.74 B	13.71%
ABT	15.34	4.18	27.26%	1.89%	$ 214.39 B	31.88%
CVS	211.13	1.35	0.64%	3.41%	$ 99.02 B	0.12%
GSK	12.93	4.43	34.29%	3.52%	$ 94.37 B	17.23%
BSX	51.42	0.00	0.00%	0.00%	$ 143.58 B	14.43%
TMDX	48.51	12.53	25.84%	0.00%	$ 4.45 B	16.20%
HCA	18.03	-52.99	-293.84%	0.57%	$ 114.40 B	8.53%
IDXX	56.52	37.20	65.81%	0.00%	$ 58.07 B	24.65%
INMD	5.92	1.36	22.89%	0.00%	$ 885.78 M	41.04%
DHR	46.15	3.17	6.86%	0.54%	$ 161.67 B	14.43%
FMS	16.76	0.84	5.00%	3.36%	$ 13.67 B	3.73%
RMD	25.40	5.97	23.49%	0.88%	$ 36.52 B	27.35%
PHG	115.12	2.09	1.81%	3.25%	$ 25.92 B	1.14%
HUM	21.11	1.47	6.95%	1.56%	$ 27.25 B	1.02%
SYK	47.80	6.46	13.51%	0.91%	$ 140.68 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NVS Historical Dividends

current DY: 3.04%

5-year average DY: 4.22%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	03/12/2025	04/25/2025	3,86950000
Dividend	03/08/2024	04/19/2024	3,77700000
Dividend	03/10/2023	03/20/2023	3,46900000
Dividend	03/09/2022	03/17/2022	3,32530000
Dividend	03/05/2021	03/15/2021	3,37800000
Dividend	03/04/2020	03/12/2020	3,04200000
Dividend	03/05/2019	03/13/2019	2,86500000
Dividend	03/07/2018	04/25/2018	2,97700000
Dividend	03/03/2017	04/20/2017	2,74600000
Dividend	02/26/2016	04/15/2016	2,76200000
Dividend	03/04/2015	04/20/2015	2,81700000
Dividend	03/03/2014	04/10/2014	2,71900000
Dividend	02/28/2013	04/05/2013	2,53000000
Dividend	02/29/2012	04/05/2012	2,46000000
Dividend	02/28/2011	04/08/2011	2,35300000
Dividend	03/04/2010	04/13/2010	1,98700000
Dividend	02/26/2009	04/06/2009	1,72000000
Dividend	02/28/2008	04/11/2008	1,47200000
Dividend	03/08/2007	04/10/2007	1,08100000
Dividend	03/02/2006	04/03/2006	0,89400000
Dividend	03/03/2005	04/06/2005	0,98570000
Dividend	02/26/2004	03/30/2004	0,80600000
Dividend	03/06/2003	04/07/2003	0,70000000
Dividend	03/25/2002	04/22/2002	0,52200000
Dividend	03/26/2001	04/20/2001	0,50200000

ABOUT THE COMPANY Novartis

Novartis AG

Average user rating I10

4.0 (79 people)

United States

29 years

Founded: 1996

1996

Time since IPO - 29 years

105.794

Employees

The Company Novartis AG (United States), is listed on NYSE with a market cap of $ 245.20 Billions, having an equity of $ 44.75 Billions.

With a total of 105.794 employees, the company is listed in the sector of Health and categorized in industry of Main Medications.

In the last 12 months the Company had a revenue of $ 56.37 Billions, which generated a profit in the amount of $ 14.39 Billions.

As for its main indicators, the Company has a P/E ratio of 17.04, a P/BV ratio of 5.48 and in the last 12 months the dividend yield of NVS was at 3.04%.

The Company is traded internationally through the ticker NVS.

Market cap

$ 245.20 Billions

Equity

$ 44.75 Billions

US$ 44,752,000,000.00

Assets

$ 107.29 Billions

US$ 107,289,000,000.00

Total Shares Outstanding

1.93 Billion

1,926,000,000

Average Daily Trading Volume

$ 1.64 Million

US$ 1,641,318.00

Sector

Health

Industry

Main Medications

NVS

NVS revenue and profits

Financial Results NVS

DRAG THE FRAME TO SEE MORE DATA

NVS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.90 35,21% (12M)

P/E

211.13

3.41%

ROE

0.64%

P/BV

1.35

CI - Cigna

$ 271.47 --16,47% (12M)

P/E

12.03

2.13%

ROE

14.63%

P/BV

1.76

CNC - Centene

$ 38.17 --37,86% (12M)

P/E

-3.39

0.00%

ROE

-25.12%

P/BV

0.85

HUM - Humana

$ 229.20 --23,29% (12M)

P/E

21.11

1.56%

ROE

6.95%

P/BV

1.47

SNY - Sanofi

$ 49.15 6,16% (12M)

P/E

10.79

4.46%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 501.04 53,80% (12M)

P/E

18.03

0.57%

ROE

-293.84%

P/BV

-52.99

LLY - Eli Lilly

$ 1,070.16 36,82% (12M)

P/E

51.55

0.55%

ROE

77.20%

P/BV

39.80

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 77.90 35,21% (12 M)

P/L

211.13

3.41%

ROE

0.64%

P/VP

1.35

CI - Cigna

$ 271.47 --16,47% (12 M)

P/L

12.03

2.13%

ROE

14.63%

P/VP

1.76

CNC - Centene

$ 38.17 --37,86% (12 M)

P/L

-3.39

0.00%

ROE

-25.12%

P/VP

0.85

HUM - Humana

$ 229.20 --23,29% (12 M)

P/L

21.11

1.56%

ROE

6.95%

P/VP

1.47

SNY - Sanofi

$ 49.15 6,16% (12 M)

P/L

10.79

4.46%

ROE

13.90%

P/VP

1.50

HCA - HCA Healthcare

$ 501.04 53,80% (12 M)

P/L

18.03

0.57%

ROE

-293.84%

P/VP

-52.99

LLY - Eli Lilly

$ 1,070.16 36,82% (12 M)

P/L

51.55

0.55%

ROE

77.20%

P/VP

39.80

Frequently Asked Questions

What is the price of Novartis (NVS) today?

The price of Novartis (NVS) today is $ 126.54, with return of 26.61% compared to the last year. The price of Novartis (NVS) started the year trading around $ 97.14 and today it is at $ 126.54. Follow the real-time price chart, the historical price of Novartis (NVS) and international markets.

When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of April, totaling $ 3.87. The Dividend Yield for the last 12 months is 3.04%.

Is Novartis (NVS) worth it?

Currently, Novartis (NVS) is priced at $ 126.54, with a P/E of 17.04%, representando um desvio de 2,448% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 26.61 in its price and distributed $ 3.87 in dividends, resulting in a Dividend Yield of 3.04%. The total shareholder return was 26.61%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Novartis (NVS) stock?

Investing in stocks of Novartis (NVS) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Novartis (NVS) yield today?

The yield of Novartis (NVS) was -2.93% in the last month, 26.61% in the last year and 83.29% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 3.87 in dividends, a Dividend Yield of 3.04%.

If you wanted to buy 100 stocks of Novartis (NVS) today, the total investment would be $ 12,654.00, based on the current price of $ 126.54.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 16,021.23
In 5 years: $ 23,193.52
In 10 years: $ 30,030.47

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NVS

Novartis AG

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of NVS

review the fundamentals of Novartis shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 3.04%

5-year average DY: 4.22%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Novartis

Novartis AG

United States

29 years

1996

105.794

PROFIT X PRICE NVS

Financial Results NVS

NVS cash flow

asset growth - NVS

NVS balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions